Suppr超能文献

益生元、益生菌、合生元和后生元对人体肠道微生物群和肠道完整性影响的综述

A Review of the Influence of Prebiotics, Probiotics, Synbiotics, and Postbiotics on the Human Gut Microbiome and Intestinal Integrity.

作者信息

Smolinska Sylwia, Popescu Florin-Dan, Zemelka-Wiacek Magdalena

机构信息

Department of Clinical Immunology, Faculty of Medicine, Wroclaw Medical University, 51-616 Wroclaw, Poland.

Department of Allergology, Nicolae Malaxa Clinical Hospital, Carol Davila University of Medicine and Pharmacy, 050474 Bucharest, Romania.

出版信息

J Clin Med. 2025 May 23;14(11):3673. doi: 10.3390/jcm14113673.

Abstract

OBJECTIVE

This review aims to comprehensively evaluate the current evidence on the role of prebiotics, probiotics, synbiotics, and postbiotics-collectively referred to as "biotics"-in modulating the human gut microbiota and enhancing intestinal epithelial integrity.

FINDINGS

Biotics exert their beneficial effects through several mechanisms, including by promoting the growth of beneficial microbes, producing short-chain fatty acids (SCFAs), strengthening the gut barrier, and regulating immune responses. Prebiotics selectively stimulate beneficial bacteria, probiotics introduce live microorganisms with therapeutic functions, synbiotics combine the strengths of both, and postbiotics offer non-viable microbial components and metabolites that mimic probiotic benefits with enhanced safety profiles. Each type of biotic demonstrates unique and complementary effects across a range of conditions, such as inflammatory bowel disease, irritable bowel syndrome, obesity, constipation, and antibiotic-associated diarrhea.

IMPLICATIONS

As disruptions in the gut microbiota and intestinal barrier are increasingly linked to chronic and immune-mediated diseases, leveraging biotics offers promising avenues for personalized nutrition, preventive healthcare, and adjunct therapies. The integration of biotics into clinical and dietary strategies may significantly contribute to improving gastrointestinal and systemic health.

摘要

目的

本综述旨在全面评估益生元、益生菌、合生元和后生元(统称为“生物活性物质”)在调节人类肠道微生物群和增强肠上皮完整性方面的现有证据。

研究结果

生物活性物质通过多种机制发挥有益作用,包括促进有益微生物的生长、产生短链脂肪酸(SCFAs)、加强肠道屏障和调节免疫反应。益生元选择性地刺激有益细菌,益生菌引入具有治疗功能的活微生物,合生元结合了两者的优势,而后生元提供无活性的微生物成分和代谢产物,模拟益生菌的益处,且安全性更高。每种类型的生物活性物质在一系列病症中都表现出独特且互补的作用,如炎症性肠病、肠易激综合征、肥胖症、便秘和抗生素相关性腹泻。

启示

由于肠道微生物群和肠道屏障的破坏与慢性疾病和免疫介导疾病的联系日益紧密,利用生物活性物质为个性化营养、预防性医疗保健和辅助治疗提供了有前景的途径。将生物活性物质纳入临床和饮食策略可能会显著有助于改善胃肠道和全身健康。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9673/12156228/e2c906c21350/jcm-14-03673-g001.jpg

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验